EDNRA and diabetic kidney disease: The proven antiproteinuric effects of Ednra blockade could be attributed to the prevention of pathologic crosstalk between podocytes and GECs in DKD, where increased Ednra signaling in GECs leads to mitochondrial oxidative stress and damage of GECs [22].